Malabsorption News

ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.

Earlier detection of celiac disease in children through mass screening or case-finding was “highly cost-effective” and improved long-term health outcomes vs. current practices, according to a study conducted in the Netherlands.

Every August, gastrointestinal care providers and patient advocacy groups celebrate Gastroparesis Awareness Month, an annual campaign focused on improving understanding of gastroparesis and promoting preventive strategies.

Tofacitinib “should be considered as a treatment option” for patients with refractory celiac disease type 2 who previously failed treatment with therapies such as budesonide, according to data in Clinical Gastroenterology and Hepatology.

A 44-year-old man presents as a new patient because he is worried that he has lost weight for no obvious reason and has been noticeably more fatigued recently. He is very worried that he has cancer.

In honor of International Celiac Awareness Day, landmarks in the U.S. and around the globe will once again light up on May 16 to promote the #ShineALightOnCeliac social media campaign to encourge awareness and additional research.

Patients with irritable bowel syndrome who tested positive for fructan or fructose malabsorption via hydrogen breath testing had nearly two times higher odds of testing positive for the other carbohydrate, according to study results.

DENVER — For those diagnosed with migraine, gastrointestinal issues or both, psychiatric comorbidities increase the risk of worsened physical and mental states, according to an expert at the American Academy of Neurology annual meeting.

Diagnostic test completion for early age-onset colorectal cancer is low among U.S. veterans presenting with iron-deficiency anemia or hematochezia, with women and Black and Hispanic veterans less likely to undergo follow-up testing.